Press releases

  • All
  • News
  • Regulatory
  • MAR
All
  • All
  • News
  • Regulatory
  • MAR

Bulletin from the annual general meeting of CombiGene AB (publ)

Read More

New issue of Ingeneious, no 2 2023

Read More

CombiGene to play an integral part in the development of a national infrastructure for ATMPs

Read More

Interim report January – March 2023 for CombiGene AB (publ)

Read More

High activity level in the pain program COZY in preparation of the final preclinical toxicology program

Read More

CombiGene AB (publ) publishes annual report for 2022

Read More

Notice of Annual General Meeting in CombiGene AB (publ)

Read More

One of Nature’s journals publishes article about CombiGene’s epilepsy project

Read More